HOUSTON, Sept. 07, 2017 -- Emerson Scott, LLP announces a continuing investigation of the Equifax data breach which may have affected 143 million or more customers and others whose personal and/or financial information was compromised while in the possession of Equifax during a period of time that currently appears to be mid-May to through July, 2017.
The cyber-attackers or hackers stole the personal information including personal financial information of consumers which includes names, addresses, birth dates, driver’s license numbers, social security numbers, and other sensitive information. The credit card numbers for 209,000 consumers were also reported stolen along with documents with personal information used in disputes for 182,000 consumers. These records are a treasure trove for hackers seeking to profit from stolen identities and this data may already be for sale by criminals on the so-called “Dark-Net”.
Equifax is a consumer credit company with corporate headquarters in Atlanta, Georgia.
Emerson Scott, LLP, with offices in Houston, TX and Little Rock, AR, is a boutique law firm specializing in results, integrity, and personal service. Emerson Scott, LLP represents consumers throughout the nation and has significant cyber-attack and data breach experience in such data breach cases as Anthem, Premera, Experian, Vizio, Office of Personnel Management (“OPM”) and Wendy’s. Emerson Scott, LLP lawyers have devoted their practice to complex commercial litigation for more than thirty years and have recovered hundreds of millions of dollars for consumers in class actions throughout the United States.
IMPORTANT: If you believe that you were affected by this data breach at Equifax or if you have received a letter or other notification from Equifax that your personal and/or financial information has been compromised or hacked then please contact us immediately to protect your rights. It makes no difference what state you reside in. Contact plaintiff’s counsel, Emerson Scott, LLP, at the following number: 281-488-8854, or via e-mail to John G. Emerson ([email protected]) or David G. Scott ([email protected]).


AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role 



